Leonard E. Post
CIK: 0001235862
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (49 total)
- Oct 15, 2026CGON
CG Oncology, Inc.
Exercise(M)Direct1K shares at avg. $0.60$600 - Oct 15, 2026CGON
CG Oncology, Inc.
Sale(S)Direct500 shares at avg. $62.48$31K - Oct 15, 2026CGON
CG Oncology, Inc.
Sale(S)Direct500 shares at avg. $61.65$31K - Sep 15, 2026CGON
CG Oncology, Inc.
Exercise(M)Direct1K shares at avg. $0.60$600 - Sep 15, 2026CGON
CG Oncology, Inc.
Sale(S)Direct1K shares at avg. $72.98$73K - Aug 14, 2026CGON
CG Oncology, Inc.
Sale(S)Direct1K shares at avg. $74.54$75K - Aug 14, 2026CGON
CG Oncology, Inc.
Exercise(M)Direct1K shares at avg. $0.60$600 - Jul 15, 2026CGON
CG Oncology, Inc.
Exercise(M)Direct1K shares at avg. $0.60$600 - Jul 15, 2026CGON
CG Oncology, Inc.
Sale(S)Direct1K shares at avg. $71.17$71K - Jun 24, 2026CGON
CG Oncology, Inc.
Exercise(M)Direct5K shares at avg. $0.60$3K - Jun 24, 2026CGON
CG Oncology, Inc.
Sale(S)Direct5K shares at avg. $70.00$350K - Jun 22, 2026CGON
CG Oncology, Inc.
Sale(S)Direct5K shares at avg. $65.00$325K - Jun 22, 2026CGON
CG Oncology, Inc.
Exercise(M)Direct5K shares at avg. $0.60$3K - Jun 11, 2026QURE
uniQure N.V.
Sale(S)Direct2K shares at avg. $27.06$54K - Jun 10, 2026QURE
uniQure N.V.
Award(A)Direct7.6K shares- - Jun 4, 2026CGON
CG Oncology, Inc.
Award(A)DirectDirector Stock Option (right to buy)
9.4K shares- - Jun 4, 2026CGON
CG Oncology, Inc.
Sale(S)Direct1K shares at avg. $54.50$55K - Jun 4, 2026CGON
CG Oncology, Inc.
Exercise(M)Direct1K shares at avg. $0.60$600 - Nov 17, 2025CGON
CG Oncology, Inc.
Sale(S)Direct1K shares at avg. $41.43$41K - Nov 17, 2025CGON
CG Oncology, Inc.
Exercise(M)Direct1K shares at avg. $0.60$600 - Oct 13, 2025CGON
CG Oncology, Inc.
Sale(S)Direct1K shares at avg. $43.25$43K - Oct 13, 2025CGON
CG Oncology, Inc.
Exercise(M)Direct1K shares at avg. $0.60$600 - Sep 30, 2025CGON
CG Oncology, Inc.
Sale(S)Direct5K shares at avg. $40.09$200K - Sep 30, 2025CGON
CG Oncology, Inc.
Exercise(M)Direct5K shares at avg. $0.60$3K - Sep 15, 2025CGON
CG Oncology, Inc.
Exercise(M)Direct1K shares at avg. $0.60$600
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 15, 2026 |  CGON CG Oncology, Inc. | Exercise(M) | 1,000 | $0.60 | $600 | Direct |
| Oct 15, 2026 | CGON CG Oncology, Inc. | Sale(S) | 500 | $62.48 | $31,240 | Direct |
| Oct 15, 2026 | CGON CG Oncology, Inc. | Sale(S) | 500 | $61.65 | $30,825 | Direct |
| Sep 15, 2026 | CGON CG Oncology, Inc. | Exercise(M) | 1,000 | $0.60 | $600 | Direct |
| Sep 15, 2026 | CGON CG Oncology, Inc. | Sale(S) | 1,000 | $72.98 | $72,980 | Direct |
| Aug 14, 2026 | CGON CG Oncology, Inc. | Sale(S) | 1,000 | $74.54 | $74,540 | Direct |
| Aug 14, 2026 | CGON CG Oncology, Inc. | Exercise(M) | 1,000 | $0.60 | $600 | Direct |
| Jul 15, 2026 | CGON CG Oncology, Inc. | Exercise(M) | 1,000 | $0.60 | $600 | Direct |
| Jul 15, 2026 | CGON CG Oncology, Inc. | Sale(S) | 1,000 | $71.17 | $71,170 | Direct |
| Jun 24, 2026 | CGON CG Oncology, Inc. | Exercise(M) | 5,000 | $0.60 | $3,000 | Direct |
| Jun 24, 2026 | CGON CG Oncology, Inc. | Sale(S) | 5,000 | $70.00 | $350,000 | Direct |
| Jun 22, 2026 | CGON CG Oncology, Inc. | Sale(S) | 5,000 | $65.00 | $325,000 | Direct |
| Jun 22, 2026 | CGON CG Oncology, Inc. | Exercise(M) | 5,000 | $0.60 | $3,000 | Direct |
| Jun 11, 2026 |  QURE uniQure N.V. | Sale(S) | 1,993 | $27.06 | $53,931 | Direct |
| Jun 10, 2026 | QURE uniQure N.V. | Award(A) | 7,550 | - | $0 | Direct |
| Jun 4, 2026 | CGON CG Oncology, Inc. | Award(A) Director Stock Option (right to buy) | 9,354 | - | - | Direct |
| Jun 4, 2026 | CGON CG Oncology, Inc. | Sale(S) | 1,000 | $54.50 | $54,500 | Direct |
| Jun 4, 2026 | CGON CG Oncology, Inc. | Exercise(M) | 1,000 | $0.60 | $600 | Direct |
| Nov 17, 2025 | CGON CG Oncology, Inc. | Sale(S) | 1,000 | $41.43 | $41,430 | Direct |
| Nov 17, 2025 | CGON CG Oncology, Inc. | Exercise(M) | 1,000 | $0.60 | $600 | Direct |
| Oct 13, 2025 | CGON CG Oncology, Inc. | Sale(S) | 1,000 | $43.25 | $43,250 | Direct |
| Oct 13, 2025 | CGON CG Oncology, Inc. | Exercise(M) | 1,000 | $0.60 | $600 | Direct |
| Sep 30, 2025 | CGON CG Oncology, Inc. | Sale(S) | 5,000 | $40.09 | $200,450 | Direct |
| Sep 30, 2025 | CGON CG Oncology, Inc. | Exercise(M) | 5,000 | $0.60 | $3,000 | Direct |
| Sep 15, 2025 | CGON CG Oncology, Inc. | Exercise(M) | 1,000 | $0.60 | $600 | Direct |
1-25 of 49 transactions
About POST LEONARD E
POST LEONARD E (SEC CIK 0001235862) files insider reports with the SEC as Director of CG Oncology, Inc. (CGON) and Director of uniQure N.V. (QURE).
Signal8 holds 25 ownership filings by POST LEONARD E, all Form 4s, filed between Oct 7, 2024 and Oct 19, 2026. Those filings report 49 transactions, from Oct 4, 2024 to Oct 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on POST LEONARD E's filings is in DALLAS, TX.
Recent filings by POST LEONARD E
- Oct 15, 2026: Option exercise of CGON shares (Form 4, code M).
- Oct 15, 2026: Open-market sales of CGON shares (2 lines, Form 4, code S).
- Sep 15, 2026: Option exercise of CGON shares (Form 4, code M).
- Sep 15, 2026: Open-market sale of CGON shares (Form 4, code S).
- Aug 14, 2026: Open-market sale of CGON shares (Form 4, code S).
Other insiders filing for CG Oncology, Inc. (CGON)
- Kalofonos Isabel, Chief Commercial Officer
- Mulay James, Director
- Liu Brian Guan-Chyun, Director
- Tong Victor Edward Jr, Director
- Rossi Christina, Director
- Graf Susan E, Director